Scientists have developed a new lung surfactant that is produced synthetically rather than relying on the use of animal tissues. With further development, the formulation could provide a cheaper and ...
Researchers conducted a meta-analysis of 12 randomized controlled trials involving 2428 premature infants, comparing intratracheal budesonide plus pulmonary surfactant with pulmonary surfactant alone.
A recently published preclinical study by researchers at Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, show that vaping may negatively affect ...
In a recent study posted to the bioRxiv* preprint server, researchers discuss the role of a surfactant-mediated inflammatory response employed by human lungs against the severe acute respiratory ...
LONDON, ON-A recently published preclinical study by researchers at Lawson Health Research Institute and Western University’s Schulich School of Medicine & Dentistry, show that vaping may negatively ...
Pulmonary surfactants are a complex assembly of lipids and proteins that play a critical role in maintaining the stability of the alveolar air–liquid interface during breathing. Their primary function ...
Usual interstitial pneumonia (UIP) is a risk factor for lung carcinogenesis. This study was performed to characterize mutagenesis and mutational target genes underlying lung carcinogenesis in patients ...
An engineer in California has an invention that she hopes will someday help people with damaged lungs breathe easier. Stanford University's Annelise Barron has developed a synthetic version of ...
Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results